CALABRESE, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 26.892
EU - Europa 2.249
AS - Asia 1.102
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
AF - Africa 5
OC - Oceania 4
Totale 30.269
Nazione #
US - Stati Uniti d'America 26.879
SG - Singapore 640
UA - Ucraina 361
DE - Germania 360
IE - Irlanda 352
IT - Italia 348
CN - Cina 337
SE - Svezia 252
FR - Francia 143
GB - Regno Unito 122
FI - Finlandia 104
KR - Corea 78
RU - Federazione Russa 68
BE - Belgio 42
CZ - Repubblica Ceca 27
PL - Polonia 27
JP - Giappone 13
IN - India 12
CA - Canada 11
NL - Olanda 9
EU - Europa 7
DK - Danimarca 6
ES - Italia 5
KG - Kirghizistan 5
BR - Brasile 4
CH - Svizzera 4
RO - Romania 4
EG - Egitto 3
GR - Grecia 3
HR - Croazia 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
DM - Dominica 2
HK - Hong Kong 2
IL - Israele 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
AL - Albania 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
TN - Tunisia 1
TR - Turchia 1
VE - Venezuela 1
Totale 30.269
Città #
Woodbridge 7.910
Wilmington 6.688
Houston 6.659
Fairfield 929
Ann Arbor 825
Singapore 565
Chandler 479
Ashburn 410
Seattle 405
Cambridge 332
Dublin 316
Jacksonville 316
Medford 239
Dearborn 184
Rome 166
Santa Clara 155
Beijing 116
Lawrence 112
New York 89
Zhengzhou 80
San Diego 65
Brussels 42
Menlo Park 40
Moscow 35
Mülheim 35
Milan 25
Helsinki 24
Kraków 24
Boardman 23
Redwood City 21
Shanghai 21
Norwalk 20
Munich 18
Brno 17
Palo Alto 16
Nanjing 14
University Park 13
Verona 13
Hefei 12
London 12
Lappeenranta 11
Seoul 11
Kilburn 10
Kunming 10
Mountain View 10
Olomouc 10
Cedarhurst 9
Saint Petersburg 8
San Mateo 8
West Jordan 8
Falls Church 7
Jinan 7
San Francisco 7
Wuhan 7
Changsha 6
Council Bluffs 6
Durham 6
Los Angeles 6
Manitou Springs 6
Copenhagen 5
Creede 5
Guangzhou 5
Hanover 5
Shenyang 5
Toronto 5
Catania 4
Del Norte 4
Fuzhou 4
Hangzhou 4
Nanchang 4
Nürnberg 4
San Jose 4
Tokyo 4
Ancona 3
Anzio 3
Auburn Hills 3
Augsburg 3
Bologna 3
Boston 3
Cairo 3
Chennai 3
Chicago 3
Chongqing 3
Detroit 3
Frosinone 3
Gravina In Puglia 3
Hebei 3
Hounslow 3
Indiana 3
Miami Beach 3
Nuremberg 3
Phoenix 3
Sannazzaro de' Burgondi 3
São Paulo 3
Trieste 3
Acton 2
Alba 2
Athens 2
Atlanta 2
Auckland 2
Totale 27.756
Nome #
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 481
Local injection of infliximab in the postoperative recurrence of Crohn's disease 462
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 461
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 449
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 444
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia 442
Cancer and immunomodulators in inflammatory bowel diseases 442
Surgery for fistula-in-ano in a specialist colorectal unit: a critical appraisal 437
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 435
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 429
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 428
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study 422
Planck 2013 results. I. Overview of products and scientific results 422
A family study of asymptomatic small bowel Crohn's disease 420
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 417
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: a prospective longitudinal study 416
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study 415
Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies 415
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 413
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: A prospective longitudinal study 411
Colonic Phenotype of the Ileum in Crohn's Disease: A Prospective Study Before and after Ileocolonic Resection. 411
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study 410
Accuracy of Small Intestine Contrast Ultrasonography, Compared to Computed Tomography Enteroclysis, in Characterizing Lesions in Patients with Crohn's Disease. 410
null 409
Measuring disease activity in Crohn's disease 409
Planck 2013 results. XV. CMB power spectra and likelihood 409
Is It Always Necessary to Treat CD Patients? 407
Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease 405
Ultrasound in Crohns Disease 405
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease. 405
Treatment with biologic therapies and the risk of cancer in patients with IBD. 405
Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic 403
Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: A novel recognizable microdeletion syndrome? 403
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 401
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 401
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study 400
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 399
Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease. 395
Frequency, Pattern, and Risk Factors of Postoperative Recurrence of Crohn's Disease After Resection Different from Ileo-Colonic 393
Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study 392
Wireless capsule endoscopy in Crohn’s disease: clinical relevance of upper GI lesions and feasibility 2 years after ileo-colonic resection. 387
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 382
Capsule endoscopy and proximal small bowel lesions in patients with Crohn’s disease. 379
Evolution of the Lesions Related to Crohn's Disease Recurrence As Assessed By Ultrasonography: A Prospective Longitudinal Study. 378
Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation 377
Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease 373
Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's disease. 370
Comparison between techniques providing the luminal vs extraluminal surface in assessing Crohn’s disease recurrance: a prospective longitudinal study. 369
In Crohn's Disease Colonic Mucins Are Expressed in the Established Ileal Lesions at Surgery While heal Mucins Are Mainly Expressed in the Early Ileal Recurrence: A Prospective Longitudinal Study 367
A Sonographic Lesion Index for Crohn's Disease Helps Monitor Changes in Transmural Bowel Damage During Therapy 365
Antisense approach to inflammatory bowel disease: Prospects and challenges 365
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis? 359
Diagnostic role of wireless capsule endoscopy in patients with symptoms highly compatible with Crohn's disease 355
Planck 2013 results. XXII. Constraints on inflation 355
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis 354
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 351
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case–control IG-IBD study 350
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 346
Ileal lesions in patients with Ulcerative Colitis after ileo-rectal anastomosis: relationship with colonic metaplasia. 341
Severity of Crohn’s disease recurrence after ileo-colon resection: correlation between endoscopic score and sonographic findings. 340
Malattia di Crohn. In: Malattie del canale digerente. Gasbarrini G, Morelli A. 333
Ultrasound of the small bowel in Crohn's disease 332
New biologic therapies in patients with Inflammatory Bowel Disease [Nuovi farmaci biologici nelle Malattie Infiammatorie Croniche Intestinali] 331
Laparoscopic versus open ileo-colonic resection in Crohn's disease: short- and long-term results from a prospective longitudinal study 327
Cancer in Infliximab treated or untreated Crohn’s disease patients: a 2 years longer follow up from a multicenter matched-pair study.. 323
Assessment of Crohn’s disease recurrence after Ileo-colonic resection: correlation between endoscopic score and sonographic findings. 318
Endoscopic vs ultrasonographic findings related to Crohn's disease recurrence: a prospective longitudinal study at 3 years. 312
Newly diagnosed neoplasia in a cohort of Crohn’s disease patients treated with Infliximab: a 3 years longer follow up from a multicenter matched-pair study. 306
Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings 297
Malattia di Crohn. In: Malattie del canale digerente 265
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 261
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 223
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 204
EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound 165
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 160
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 158
Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts. 135
Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease 132
Response assessed by Ultrasonography as Target of Biological Treatment for Crohn's disease: Treat to target in CD using Ultrasonography 127
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study. 126
1 119
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 108
Hepatic follicular lymphoma in an old patient with Crohn’s disease: a rare case and review of the literature 97
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 89
The impact of COVID-19 pandemic in the colorectal cancer prevention 87
ECCO-ESGAR guideline for diagnostic assessment in ibd part 2: Ibd scores and general principles and technical aspects 81
Crohn's disease: A comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema 56
Why do we Still Use 5-ASAs in Crohn's Disease? 54
Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice 54
Onset of ulcerative colitis during SARS-Cov-2 infection 52
Post-operative recurrence of Crohn's disease: A prospective study at 5 years 52
Treatment with biologic therapies and the risk of cancer in patients with IBD 51
EFSUMB Gastrointestinal Ultrasound (GIUS) Task Force Group: Celiac sprue and other rare gastrointestinal diseases ultrasound features 50
Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases 50
EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Inflammatory Bowel Diseases 48
EFSUMB Position Paper: Recommendations for Gastrointestinal Ultrasound (GIUS) in Acute Appendicitis and Diverticulitis 45
The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapies 44
Noninvasive imaging in Crohn's disease assessment 43
Concept design of the LiteBIRD satellite for CMB B-mode polarization 43
Effect of Vedolizumab on anemia of chronic disease in patients with inflammatory bowel diseases 42
Totale 30.096
Categoria #
all - tutte 64.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.558 0 0 486 699 660 843 670 657 692 651 663 537
2020/20215.329 568 645 534 619 499 597 774 526 106 173 208 80
2021/20221.428 54 145 73 121 80 100 70 70 220 116 65 314
2022/20231.318 162 101 22 168 124 332 120 64 110 7 73 35
2023/2024537 56 17 37 16 63 127 38 55 5 22 8 93
2024/20251.203 93 733 377 0 0 0 0 0 0 0 0 0
Totale 30.774